AllPennyStocks.com Pharma Firm Shares Rips After Acquiring New Parkinson’s Drug
AllPennyStocks.com

Pharma Firm Shares Rips After Acquiring New Parkinson’s Drug

Pharma Firm Shares Rips After Acquiring New Parkinson’s Drug By: Tomas Ronolski - AllPennyStocks.com News

Monday, June 7, 2021

An old drug could give new life to Parkinson’s patients and this biopharma company is on fire after signing a letter of intent to acquire it. 

A certain class of Parkinson’s drug could have substantial benefits over current treatments and Adhera Therapeutics, Inc. (OTCPK:ATRX) a clinical stage biopharmaceutical company, is about to benefit. The company signed a Letter of Intent with Melior Pharmaceuticals II, LLC  to acquire MLR-1019 (armesocarb) from Melior Pharma 2. The drug is being developed as a new class of therapeutic for Parkinson’s disease is believed to be the only drug candidate today to address both movement and non-movement aspects of the disease.

The drug Armesocarb was previously sold in Europe for 37 years for Parkinson’s and was marketed for select psychiatric and central nervous system (CNS) indications until 2008. The Russian manufacturer then discontinued operations for business reasons unrelated to the compound itself. The companies believe the drug represents a significant opportunity to address a large gap in therapeutics for Parkinson’s.

Shares popped, jumping over 290% in late morning trade. 


Copyright © 2021 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Junior Launches 10,000 Meter Drill Program in America's Newest Cu Mining Belt
 Read More
Micro-Cap Mining Stock Climbs After Securing Option on Idaho Property
 Read More
Red Lake Explorer Rises 12% on High-Grade Gold Below Historic Cole Shaft
 Read More
Most Popular
{{ index + 1 }}
{{ item.title }}


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2026 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2026. AllPennyStocks.com Media Inc.
All rights reserved.